Chemotherapy for small cell lung cancer: a comprehensive review
Combination chemotherapy is the current strategy of choice for treatment of small cell lung cancer (SCLC). Platinum containing combination regimens are superior to non-platinum regimens in limited stage- SCLC and possibly also in extensive stage-SCLC as first and second-line treatments. The addition...
Saved in:
Main Authors: | Syed Mustafa Karim (Author), Jamal Zekri (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2012-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic evaluation of drug supply for chemotherapy in small cell lung cancer
by: Yelena A. Lunyova
Published: (2023) -
Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011) -
Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011) -
Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review
by: Tao Wang, et al.
Published: (2023) -
Sugemalimab plus chemotherapy vs. chemotherapy for metastatic non-small-cell lung cancer: A cost-effectiveness analysis
by: Xueyan Liang, et al.
Published: (2023)